Stocklytics Platform
Asset logo for symbol HRTX
Heron Therapeutics
HRTX56
$1.73arrow_drop_down1.42%-$0.02
Penny Stock
Asset logo for symbol HRTX
HRTX56

$1.73

arrow_drop_down1.42%

Performance History

Chart placeholder
Key Stats
Open$1.77
Prev. Close$1.75
EPS-0.16
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$272.24M
PE Ratio-
LOWHIGH
Day Range1.71
1.87
52 Week Range0.50
3.93
Ratios
EPS-0.16

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Heron Therapeutics (HRTX)

Heron Therapeutics Inc. (HRTX) is a biotechnology company that focuses on developing treatments for pain and other diseases. The company's stock price history has shown both ups and downs over the years. Investors have closely followed the company's progress and news to determine the potential for growth. Recently, the stock has experienced some volatility due to market conditions and industry trends. However, the company continues to innovate and develop new therapies.
In terms of its stock analysis, Heron Therapeutics Inc. (HRTX) has a market cap that reflects its value in the market. The company's PEG ratio is an important metric that investors use to assess its growth prospects. A low PEG ratio indicates that the stock may be undervalued and could be a good investment opportunity. Heron Therapeutics Inc. (HRTX) strives to outperform the industry and provide value to its shareholders.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Craig Alexander Collard
Headquarters
San Diego
Employees
203
Exchange
NASDAQ
add Heron Therapeutics  to watchlist

Keep an eye on Heron Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Heron Therapeutics 's (HRTX) price per share?

The current price per share for Heron Therapeutics (HRTX) is $1.74. The stock has seen a price change of -$0.02 recently, indicating a -1.43% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Heron Therapeutics (HRTX)?

For Heron Therapeutics (HRTX), the 52-week high is $3.93, which is 126.51% from the current price. The 52-week low is $0.5, the current price is 247% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Heron Therapeutics (HRTX) a growth stock?

Heron Therapeutics (HRTX) has shown an average price growth of -2.59% over the past three years. It has received a score of 7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Heron Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Heron Therapeutics (HRTX) stock price performance year to date (YTD)?

As of the latest data, Heron Therapeutics (HRTX) has a year-to-date price change of -8.2%. Over the past month, the stock has experienced a price change of -5.71%. Over the last three months, the change has been -4.14%. Over the past six months, the figure is -52.98%. Looking at a longer horizon, the five-year price change stands at -93.23%.
help

Is Heron Therapeutics (HRTX) a profitable company?

Heron Therapeutics (HRTX) has a net income of -$110.56M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 48.75% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -13.59% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $127.04M, with a revenue growth rate of 17.99%, providing insight into the company's sales performance and growth. The gross profit is $61.94M. Operating income is noted at -$110.62M. Furthermore, the EBITDA is -$5.7M.
help

What is the market capitalization of Heron Therapeutics (HRTX)?

Heron Therapeutics (HRTX) has a market capitalization of $272.25M. The average daily trading volume is 1.79, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level